# Teicoplanin-based Antimicrobial Therapy in Staphylococcus Aureus Bone and Joint Infection: Tolerance, Efficacy and Experience With Subcutaneous Administration

> **NCT03177369** · — · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 60 (actual)

## Conditions studied

- Teicoplanin-based Antimicrobial Therapy
- Staphylococcus Aureus
- Bone and Joint Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03177369
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03177369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03177369, "Teicoplanin-based Antimicrobial Therapy in Staphylococcus Aureus Bone and Joint Infection: Tolerance, Efficacy and Experience With Subcutaneous Administration". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03177369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*